To assess the impact of therapeutic drug monitoring on clinical outcome, 171 patients with recently diagnosed epilepsy were randomized to two groups. In one group, drug dosage was individualized according to clinical response, whereas in the other group treatment was aimed at obtaining serum drug concentrations within the optimal range. At a preliminary analysis after a mean follow-up of 14 months, no major differences in seizure control or prevalence of adverse events emerged between the two groups. In both groups, more than 60% of patients remained seizure free after initiation of therapy.
|Translated title of the contribution||A prospective randomized study on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy: Interim evaluation|
|Number of pages||3|
|Journal||Bollettino - Lega Italiana contro l'Epilessia|
|Publication status||Published - 1996|
ASJC Scopus subject areas
- Clinical Neurology